Quick Answer
Galmed Pharmaceuticals Ltd. reported Common Stock Shares Outstanding of 6.58 million shares for the year ending 2025.
- Galmed Pharmaceuticals Ltd. showed an increase of +295.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Galmed Pharmaceuticals Ltd.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Galmed Pharmaceuticals Ltd.'s Common Stock Shares Outstanding has grown by 67,477.7%.
- Historical annual values: Fiscal year 2025: 6.58 million shares | Fiscal year 2024: 1.66 million shares | Fiscal year 2023: 573,741 shares | Fiscal year 2022: 1.69 million shares | Fiscal year 2021: 25.09 million shares | Fiscal year 2020: 21.33 million shares | Fiscal year 2019: 21.14 million shares | Fiscal year 2018: 21.02 million shares | Fiscal year 2017: 14.44 million shares | Fiscal year 2016: 12.15 million shares | Fiscal year 2015: 11.10 million shares | Fiscal year 2014: 11.10 million shares | Fiscal year 2013: 9,739 shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: